Confo Therapeutics NV

Industry

  • Biotechnology
    • Drug Discovery Technologies
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
See more in Biomedtracker

Latest on Confo Therapeutics NV

Scrip

Deal Watch: Tourmaline Will Pursue Its Thyroid Eye Disease Ambitions Following Merger With Talaris

 
• By Joseph Haas, Ian Haydock, and Lisa Takagi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Talaris Calls It Quits In Reverse-Merge

Scrip

Deal Watch: Japan’s JCR Inks Pacts With Sumitomo Dainippon, Alexion

 
• By Joseph Haas, Lisa Takagi, Jung Won Shin, and Ian Haydock

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. JCR Signs Deal With Sumitomo On Izcargo

Scrip

Deal Watch: Lilly Teams With Regor On Metabolic Disorders

 
• By Joseph Haas and Dexter Jie Yan

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly Doubles Down On Metabolic Disorde

Scrip

Finance Watch: $2.2bn In New Funding Sources In February, So Far

 
• By Mandy Jackson

Halfway through February, seven different sources of funding for health care and life science innovations have announced newly raised pools of cash totaling $2.2bn for a wide array of technologies, in